Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-094147
Filing Date
2025-07-07
Accepted
2025-07-07 09:16:40
Documents
2
Period of Report
2025-07-07

Document Format Files

Seq Description Document Type Size
1 6-K press_release_july_7_202.htm 6-K 25514
2 EX-99.1 ipa-ex99_1.htm EX-99.1 17410
  Complete submission text file 0000950170-25-094147.txt   43979
Mailing Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701
Business Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 251107122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)